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(57) ABSTRACT 
Strain gauges that can provide information with regard to the 
state of implantable devices are described. The strain gauges 
can exhibit luminescence that is detectable through living 
tissue, and the detectable luminescent emission can vary 
according to the strain applied to the gauge. A change in 
residual strain of the device can signify a loss of mechanical 
integrity and/or loosening of the implant, and this can be 
non-invasively detected either by simple visual detection of 
the luminescent emission or through examination of the emis-
sion with a detector such as a spectrometer or a camera. 
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LUMINESCENT TENSION-INDICATING 
ORTHOPEDIC STRAIN GAUGES FOR 
NON-INVASIVE MEASUREMENTS 
THROUGH TISSUE 
CROSS REFERENCE TO RELATED 
APPLICATION 
This application claims filing benefit of U.S. Provisional 
Patent Application Ser. No. 61/680,419 having a filing date of 
Aug. 7, 2013, which is incorporated herein by reference. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
This invention was made with government support under 
grant no. NNX I OAM76H awarded by NASA and under grant 
nos. RR021949 and GM103444 awarded by the NIH. The 
government has certain rights in the invention. 
BACKGROUND 
Over 28 million musculoskeletal injuries are treated annu-
ally in the US, including approximately 2 million fracture 
fixation surgeries. While fixation is highly effective, refrac-
ture, malunion and non-union can occur, especially if load 
bearing begins before proper healing. Other potential prob-
lems include loosening from infection (5-10% of cases) and 
asceptic loosening. All of these problems relate to the 
mechanics of the implant and bone, and methods to detect the 
in situ stress are important in determining proper treatment 
course. 
There are two known classes of fixation devices: external 
fixation devices, where pins pass through the skin and are 
locked with an external plate, and internal devices, with all 
materials implanted. External devices can be easily instru-
mented with electronic strain sensors and bone stiffness can 
be measured by applying known stresses to the pins and 
measuring the resulting strain. These external measurements 
are a highly promising diagnostic for bone healing. The rate 
of stiffening has been used to diagnose non-union, and using 
specific stiffness endpoints can reduce the average time until 
load bearing by weeks while also reducing the number of 
refractures due to premature load bearing in unhealed frac-
tures. However, external fixation devices are more prone to 
infection than internal fixation devices and are less often 
used. For internal fixation devices, currently available strain 
sensors (e.g. resistive and capacitive strain gauges, fiber optic 
Bragg gratings, ultrasound of liquid-filled cavities, X-ray 
diffraction, optical moire pattern analysis, and video track-
ing) are either unsuitable for non-invasive transdermal mea-
surements or require relatively large and complex devices for 
power, detection, and telemetry. 
In addition to fracture fixation, mechanical measurements 
are also important in many other biomedical applications, 
including tendon repair. For example, the ability to make 
direct assessments of the mechanical capabilities of a tendon 
may help to prevent failures in various types of tendon repairs, 
such as rotator cuff repairs. 
There are various known methodologies for measuring 
strain and displacement in the absence of tissue, such as 
various optical-based methods. Specifically, Moire pattern 
analysis and photoelastic polarimetry are used to map strain 
fields, while video tracking is used to track the position of 
individual mechanical components. For example video track-
ing was used to measure the position of dots drawn on a 
tendon during stress in a cadaveric model in order to deter- 
2 
mine strain on the implant. The position and velocity of 
motors and stages are also often measured using the reflection 
from optically patterned rotational and linear optical encod-
ers. In addition, strain indicating bolts are known that include 
5 a component that changes color based upon displacement of 
fluid during bolt elongation and relative displacement of two 
components. However, it has been found that the above opti-
cal techniques are insufficient for measuring implanted medi-
cal devices through tissue for three principle reasons. First, 
10 
when using any of such optical techniques, most of the inci-
dent ambient light reflects directly from the skin and super-
ficial tissue providing a large background that obscures the 
very dim signal from light which penetrates through the tis- 
15 sue, reflects from the optical strain gauge, and penetrates back 
through the tissue and skin. Second, even if there is no back-
ground, optical scattering of the reflected light in the tissue 
results in blurring of the image, with a point spread function 
approximately equal to the depth through the tissue. Third, 
20 the point spread function depends significantly upon the 
sample orientation and depth. Thus strain measurements that 
depend on optical imaging will not work through tissue. 
Electrical impedance and optical fiber strain gauges have 
also been developed for studying dynamic strain in vivo, but 
25 these require transdermal wires which can easily lead to 
infection. In addition, wireless devices have been developed, 
but these require complex electronics for power, sensing, and 
telemetry, which limits the size and necessitates significant 
modification of the implants. Non-invasive methods usually 
30 
rely upon tracking the position of fiduciary markers using 
X-ray or ultrasound imaging, but these are ineffective at mea-
suring displacements less than about 100 micrometers (µm). 
X-ray images also require acquisition at multiple angles to 
35 account for changes in sample position and angle. 
What are needed in the art are strain gauges that allow for 
displacement and/or strain on musculo skeletal structures and/ 
or implantable devices to be measured optically through liv-
ing tissue without the need for invasive technologies so as to 
40 limit patient stress and infection opportunities. 
SUMMARY 
According to one embodiment, disclosed is an implantable 
45 strain gauge. More specifically, the implantable strain gauge 
can include a first plate and a second plate that are held at a 
distance from one another and that are configured to be 
implanted within tissue. The second plate of the strain gauge 
includes a window. The secondplate is movable relative to the 
50 first plate from a first position to a second position. In addi-
tion, the strain gauge includes a luminescent material. For 
instance the luminescent material can be on an upper surface 
of the first plate. An emission of the luminescent material is 
detectable through tissue. At the first position, the emission of 
55 the first luminescent material is detectable through the win-
dow. At the second position there is either no luminescent 
emission detected through the window or a second emission 
is detected through the window that differs from the emission 
60 that is detected through the window at the first position. 
Implantable devices comprising the strain gauges are also 
disclosed. Devices can include, for example, fixation devices 
such as bolts, screws, pins, etc. as well as less rigid implants 
such as implantable gels. 
65 	 Also disclosed is a method for detecting loads on an 
implant. The method includes detecting through living tissue 
two or more emissions from a strain gauge that is a compo- 
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nent of the implant and determining a variation in strain being 
placed on the implant according to the variation between the 
first and second emissions. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1 schematically illustrates one embodiment of an 
implantable strain gauge as disclosed herein. 
FIG. 2 illustrates top views of a strain gauge in a first 
position (FIG. 2A) and in a second position (FIG. 213) with 10 
different luminescent spectra visible at each position. 
FIG. 3 illustrates one pattern of luminescent material as 
may be incorporated in a strain gauge. 
FIG. 4 schematically illustrates another embodiment of an 15 
implantable strain gauge as disclosed herein. 
FIG. 5 illustrates the intensity of luminescence for a strain 
gauge as illustrated in FIG. 4 under low and increased pres-
sure. 
FIG. 6 schematically illustrates one embodiment of an 20 
implantable tension indicating bolt as may incorporate the 
strain gauge of FIG. 1. 
FIG. 7 schematically illustrates one embodiment of an 
implantable tension indicating bolt as may incorporate the 
strain gauge of FIG. 4. 25 
FIG. 8 graphically illustrates the response of a strain gauge 
to stress. 
FIG. 9 illustrates a strain gauge measuring the strain 
between two surfaces including images of the gauge under 
low stress (FIG. 9A and FIG. 913) and under high stress (FIG. 30 
9C). 
FIG. 10A illustrates one embodiment of a detection 
method for utilization in conjunction with a strain gauge. 
FIG. 10B illustrates a strain gauge under no tension and 
FIG. 10C presents the luminescent intensity spectrum of the 35 
gauge of FIG. 10B. 
FIG. 10D illustrates the strain gauge of FIG. 10B under 
tension and FIG.10E presents the luminescent intensity spec-
trum of the gauge of FIG. 10D. 
FIG. 1OF presents the intensity spectrum versus time for 40 
the strain gauge of FIGS. 1OB -10E as tension is applied to the 
gauge. 
DETAILED DESCRIPTION 
45 
Reference now will be made in detail to various embodi-
ments of the disclosed subject matter, one or more examples 
of which are set forth below. Each example is provided by 
way of explanation, not limitation. In fact, it will be apparent 
to those skilled in the art that modifications and variations 50 
may be made in the present disclosure without departing from 
the scope or spirit of the subject matter. For instance, features 
illustrated or described as part of one embodiment may be 
used on another embodiment to yield a still further embodi-
ment. Thus, it is intended that the present disclosure covers 55 
such modifications and variations as come within the scope of 
the appended claims and their equivalents. 
In general, the present disclosure is directed to strain 
gauges that can provide information with regard to the state of 
implantable devices. More specifically, the strain gauges can 60 
exhibit luminescence that is detectable through living tissue, 
and the detectable luminescent emission can vary according 
to the strain applied to the gauge. A change in strain of the 
device can signify a loss of mechanical integrity and/or loos-
ening of the implant, while increases in stiffness and load 65 
sharing can indicate normal bone healing processes. These 
strain measurements can be non-invasively detected either by  
4 
simple visual detection of the luminescent emission or 
through examination of the emission with a detector such as 
a spectrometer or a camera. 
The strain gauge can be sensitive, robust, and show mini-
mal sensitivity to changes in observation distance and angle. 
The strain gauge can also provide desired information both 
rapidly and remote to the implant site of the gauge so as to 
provide a route to verify strain in structural components of 
implantable devices. In one embodiment, high resolution 
strain gauges can be formed that can provide information with 
regard to minute changes, for instance during structural load-
ing. 
In one embodiment, the strain gauge can be a moire-type 
strain gauge that includes a pattern of one or more lumines-
cent materials on a plate and a window over the plate through 
which an element of the luminescent pattern can be detected. 
The plate and window can be located on or in an implantable 
device such that displacement of the window with respect to 
the plate when the gauge is under tension causes the lumines-
cent pattern that is detected through the window to change. In 
another embodiment, the strain gauge can include a lumines-
cent material that will exhibit a variation in emission (e.g., 
intensity variation, emission wavelength variation, etc.) 
under pressure variation. For instance, the strain gauge can 
include a luminescent material in conjunction with an elas-
tomer and when the gauge is under tension the elastomer can 
apply pressure to the luminescent material causing a variation 
in the luminescent emission that is visible through the win-
dow layer of the gauge. 
It should be appreciated that, as used herein, the term 
"window" generally refers to any opening(s), material(s), 
surface feature(s) and/or the like that provides for the trans-
mission of a luminescent emission therethrough. For 
instance, as will be described below, windows may be formed 
via openings defined in an upper plate of the disclosed strain 
gauge, with such openings remaining un-filled or being filled-
in with a transparent or semi-transparent material(s). Alter-
natively, windows may be defined in the upper plate by form-
ing all or portions of the plate with a transparent or semi-
transparent material(s). For example, in a specific 
embodiment, the entire upper plate may be formed from a 
transparent material(s), with one or more coatings being 
applied to the upper plate to form windows therein. 
Beneficially, the gauge can be formed with high sensitivity 
such that it is sensitive to very small displacements, for 
instance displacements a fraction of a width of a pattern 
element in moire-type gauge, with sensitive limitations pri-
marily being due to limits on printing uniformity and/or lumi-
nescent material/window alignment. The disclosed strain 
gauges do not depend upon the angle or precise placement of 
the strain gauge in order to obtain useful information. Min-
iature gauges can be readily fabricated and applied to surfaces 
of implantable devices. 
Referring to FIG. 1, one embodiment of a strain gauge 1 is 
illustrated. The strain gauge 1 includes an upper plate 2 and a 
lower plate 4 held at a distance from one another. The sub-
strate material that forms the upper plate 2 and the lower plate 
4 can be the same or different from one another. For instance, 
in one embodiment, the lower plate 4 can be rigid, while the 
upper plate 2 can exhibit an amount of flexibility. In any case, 
both the upper plate 2 and the lower plate 4 can be formed of 
biocompatible, implantable materials including polymers, 
metals, ceramic, or composite materials including a combi-
nation of implantable materials. By way of example, and with 
no limitation, the upper plate 2 and lower plate 4 can include 
implantable polymers such as polyetheretherketone (PEEK), 
polyetherketone (PEK), polyaryletherketone (PAEK), poly- 
US 9,179,865 B2 
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6 
ethylene, polycarbonates, polyurethanes, and so forth. A 
	
The luminescent material can include fluorescent or phos- 
polymeric material can include a polymer in conjunction with 	 phorescent dyes. Near infrared fluorophores can include, 
additives as are known in the art, such as reinforcement fibers 	 without limitation, IRdye800CWTM (available from LiCOR) 
formed of glass, ceramic, polymers, etc. 	 and CY7 (available fromAmersham), as well as near infrared 
The upper plate 2 can include one or more windows 10. The 5 lanthanide chelates. Other red and near infrared emitting fluo- 
windows 10 can be openings formed in the upper plate 2, with 	 rophores as may be utilized include cyanine dyes such as Cy5, 
no material covering the windows 10, or can be formed of a 	 Cy5.5, and Cy7 (Amersham Biosciences, Piscataway, N.7., 
solid transparent or semi-transparent material, such as a glass 	 USA) or a variety of Alexa Fluor dyes such as Alexa Fluor 
or transparent polymer (e.g., polyacrylic). Alternatively, the 	 633, Alexa Fluor 635, Alexa Fluor 647, Alexa Fluor 660, 
upper plate 2 may be formed from a transparent material(s), io Alexa Fluor 680, Alexa Fluor 700, andAlexa Fluor 750 (Mo- 
with one or more coatings being applied to the transparent 	 lecular Probes-Invitrogen, Carlsbad, Calif., USA), and the 
plate to form the windows 10. In such an embodiment, the 	 like. Other fluorophores as may be utilized include those 
coating(s) applied to the upper plate 2 need not be just trans- 	 described in U.S. Pat. No. 8,372,868 to Bornhop, et al., U.S. 
parent or opaque. For instance, one or more different colored 
	
Pat. No. 8,280,484 to Boyden, et al., and U.S. Patent Appli- 
coatings may be applied to the upper plate 2 to create semi-  15 cation Pub. No. 2005/0171434 to Madden, et al., all of which 
transparent windows. 	 are incorporated herein by reference. 
The windows 10 of the upper plate 2 canbe formed accord- 	 Red and near infrared phosphorescent dyes can be utilized 
ing to any suitable process. For instance, in one embodiment, 	 including, without limitation, phosphorescent transition- 
a solid plate can first be formed and then material can be 	 metal complexes including Cu(I), Cu(II), Cr(III), Re(I), 
removed from the plate in select areas to create the windows 20 Re(III), Ru(II), Os(II), Ir(III), Pt(II), Pd(II), Au(I), andAu(III) 
in the plate. In those embodiments in which the windows are 	 complexes such as metallated quinones, phosphorescent met- 
formed of a transparent material, a multi-layered plate can be 	 alloporphyrins, and the like. Some suitable porphyrin com- 
formed that includes a first layer of a transparent material and 	 plexes include, but are not limited to, platinum (II) copropor- 
an adjacent layer of an opaque material. The opaque material 	 phyrin-I and III, palladium (II) coproporphyrin, ruthenium 
can then be removed in selected areas to leave the transparent 25 coproporphyrin, zinc(II)-coproporphyrin-I, derivatives 
windows in the plate. 	 thereof, and so forth. Similarly, some suitable porphine com- 
Any removal process can be utilized in forming the win- 	 plexes include, but not limited to, platinum(II) tetra-meso- 
dows 10. By way of example, plasma etching, dry etching, 	 fluorophenylporphine, platinum(II) octaethylporphine 
chemical etching, laser etching and the like can be utilized. 	 ketone (PtOEPK), and palladium(II) tetra-meso-fluorophe- 
The lower plate 4 is patterned with areas 14 that include a 3o nylporphine. Bipyridine metal complexes may also be uti- 
luminescent material. For instance, the luminescent material 
	
lized, examples of which include, but are not limited to, 
can lie between the upper plate 2 and the lower plate 4. In one 	 bis[(4,4'-carbomethoxy)-2,2'-bipyridine] 2-[3-(4-methyl-2, 
embodiment, second areas 12 can also include a luminescent 	 2'-bipyridine-4-yl)propyl]-1,3-dioxolane ruthenium (II); his 
material for which the luminescent emission differs from that 	 (2,2'-bipyridine)[4-(butan-1 -al)-4'-methyl-2,2'-bi-pyridine] 
of the luminescent material of the first areas 14. In another 35 ruthenium 	 (II); 	 bis(2,2'-bipyridine)[4-(4'-methyl-2,2'- 
embodiment, the second areas 12 do not include a lumines- 	 bipyridine-4'-yl)-butyric acid]ruthenium (II); tris(2,2'- 
cent material, but in either case, the areas 14, 12 can be 	 bipyridine)ruthenium (II); (2,2'-bipyridine) [bis-bis(1,2- 
differentiated from one another by the differences in lumi- 	 diphenylphosphino)ethylene] 	 2-[3-(4-methyl-2,2'- 
nescent characteristics of the areas. 	 bipyridine-4'-yl)propyl]-1,3-dioxolane osmium (II); bis(2,2'- 
The luminescent material(s) included in the strain gauge 4o bipyridine)[4-(4'-methyl-2,2'-bipyridine)-butylamine] 
can be any luminescent material for which the emission can 	 ruthenium (II); bis(2,2'-bipyridine)[1-bromo-4(4'-methyl-2, 
be detected through tissue. For instance, the emission can be 	 2'-bipyridine-4-yl)butan-e]ruthenium 	 (II); 	 bis(2,2'- 
detected through about 10 centimeters or less of tissue, about 	 bipyridine)maleimidohexanoic 	 acid, 	 4-methyl-2,2'- 
8 centimeters or less of tissue, or about 5 centimeters or less 	 bipyridine-4'-butylamide ruthenium (II), and so forth. 
of tissue. In one embodiment, the emission of the luminescent 45 	 In one embodiment, the luminescent materials can be pro- 
material can be detected through about 0.3 centimeters to 	 vided in the form of particles. For example, upconversion or 
about 10 centimeters of tissue, or about 1 centimeter to about 	 surface enhanced Raman spectroscopy (SERS) micro- or 
5 centimeters of tissue. 	 nanoparticles can be utilized as a luminescent material that 
In general, the luminescent material canbe excited to emis- 	 can, in one embodiment, utilize near infrared upconversion or 
sion and can emit at a wavelengththat canbe detected through 5o radioluminescence. Upconversion particles can absorb near 
tissue. For instance, the luminescent material can emit at 	 infrared (NIR) excitation light (e.g. from a 980 nm diode 
visible to near infrared wavelengths (e.g., from about 390 	 laser) and emit shorter wavelength fluorescence in the visible 
nanometer to about 1500 nanometers) and in one embodi- 	 through near infrared spectrum. Because the particles absorb 
ment at red to near infrared wavelengths (e.g., from about 600 	 near infrared photons sequentially, the multiphoton cross- 
nanometers to about 1500 nanometers) so as to be detectable 55 section is orders of magnitude smaller than tissue, and exci- 
through tissue either visually or by use of a suitable detector 	 tation intensities of mW/cm 2 can be sufficient for intense 
such as a camera or a spectrometer. The luminescent emission 	 excited upconversion with essentially no tissue autofluores- 
of the materials can be excited by any suitable irradiation. In 	 cence. For applications requiring continuous acquisition over 
one embodiment, the luminescent emission can be excited by 	 long periods, for instance to study dynamics of a system, it 
near-infrared, infrared, or X-ray irradiation, providing an 60 may be preferred to utilize upconversion particles, as they do 
essentially background-free signal able to penetrate through 	 not require ionizing radiation. 
several centimeters of tissue. In one embodiment, the lumi- 	 Upconversion particles can include, without limitation, 
nescent material can utilize infrared/near infrared excitation 	 rare-earth doped inorganic particles, especially those doped 
as well as infrared/near infrared emission, this can provide a 	 withYb and excited with 980 mu light, or Er, and excited by 
strain gauge that presents minimal photodamage as well as 65 1523 mu, such as but not limited to NaYF 4:Yb/L, NaLuF 4 : 
minimal background autofluorescence interference from sur- 	 Yb/L, NaYF4 :Er, Gd2O2 S:Yb/L, Y2BaZno5 ,Yb/L, Y2O1 : 
rounding biomolecules. 	 Yb/L, LuPO4:Yb/L, YbPO4:L. BaC1 2 :Dy/Er NaGdF4:Yb/L, 
US 9,179,865 B2 
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8 
where L is a dopant such as Eu, Er, Tb, Ce, Pr, Nd, Dy, Ho, 	 aligned with a window 10. Upon displacement of the upper 
Sm, Tm, Tb, Mn. The particles may also be excited by 	 plate 2 with respect to the lower plate 4 each area 14 will 
sequential absorption 1523 mu light in Er doped materials as 	 become visible through the windows 10. This will alter the 
well as absorption of light from excited states using two or 	 visible luminescence emission, for instance due to a loss or 
more different wavelengths of light. The particles may have 5 gain of an emission, through a variation in emission wave-
internal cores including iron oxide cores, and external shells 	 length, emission lifetime, or the like. 
such as CaF 2 and organic components. 	 FIG. 2 illustrates one embodiment in which the strain 
Radioluminescent particles that generate visible lumines- 	 gauge is at rest at FIG. 2A and under tension at FIG. 2B. As 
cence upon X-ray irradiation can be utilized as a luminescent 	 can be seen, at FIG. 2A a first, darker color is visible through 
material. X-ray irradiation can provide higher resolution io the windows 10, while at FIG. 213, the upper plate has moved 
imaging to, e.g., resolve multiple strain gauges at different 	 and a lighter color is visible through the windows 10. 
locations on an implant. For example, 300 µm resolution, 	 The pattern of luminescent material can be formed accord- 
limited by the X-ray beam width, can be utilized to map strain 	 ing to any suitable process. For example, areas of luminescent 
fields by measuring strain at multiple locations, each with its 	 material can be fabricated on a substrate by inkjet printer, 
own luminescent strain sensor, or measure the luminescent 15 which can form pattern elements of about 1 mm or less, about 
pattern after passing through a moire patterned surface or 	 800 µm or less, or about 600 µm or less in width and any 
photoelastic material between cro ss-polarizers attached to the 	 suitable length. 
implant surface. X-ray excited materials can include, without 	 To increase sensitivity, for instance to quantify minute 
limitation, NaI, CsI, SrI 21  CaWO41  lanthanide halide scintil- 	 changes in strain during structural loading and vibration, the 
lators doped with a rare earth dopant such as Ce, Tb, or Eu, 20 line width of a patterned area 14 can be small. For instance, 
Gd2O3 , Eu:CdTe quantum dots, anthracene nanoparticles, 	 the line width of a pattern element can be reduced by use of 
and Tb labeled actin. In one embodiment, europium and 
	
highresolution inkj et photo printers, which can form a pattern 
cesium doped LaF 3 and LuF 3 nanoparticles can be utilized as 	 element about 60 micrometers or less in width (e.g. 9600x 
these materials have a high quantum efficiency and reason- 	 2400 dpi corresponds to 52 µm for lines that are 20 dots wide 
able stability. In another embodiment, Gd 2O2 S:Eu nanopar-  25 and arbitrarily long). For further reduction, photolithography 
ticles can be used that are also highly luminescent and can be 	 or micro-ink printing using a bioforce enabler can be utilized, 
fabricated with a wide range of sizes and shapes including 	 which can form a pattern element to a width of less than about 
core-shell particles with multiple functionalities to the cores 	 30 micrometers in width, for instance from about 1 microme- 
and shells (e.g. an upconversion core, a spacer layer, and a 	 ters to about 20 micrometers in width. Photolithography, 
radioluminescent shell). Gd2O2S: Tm particles can be utilized 30 imprint lithography, and electron beam lithography may be 
in one embodiment. These particles are non-cytotoxic up to 1 	 used to make even smaller features. The approach can be 
mg/mL, are well characterized as MRI contrast agents, and 	 scaled up using printing press techniques, such as reel-to-reel 
have intense upconversion and radioluminescence signals. 	 flexo-printing. Fine features may also be formed by recursive 
Rare earth based oxide/oxysulfide particles can be utilized in 	 sequential deposition of layers onto a substrate (e.g. printing 
one embodiment as they are quite photostable, have long 35 a 10 µm black layer, followed by a clear layer, followed by a 
lifetime, and easily distinguished narrow spectral peaks. 	 black layer etc., or sequential deposition using electrochemi- 
In general, a microparticle can have an average diameter of 	 cal approaches), with this substrate then being sectioned ver- 
less than about 900 micrometers (µm), less than about 500 	 tically. 
µm, or less than about 100 µm. A nanoparticle generally 	 While the luminescent materials can be located on a sur- 
includes a particle having an average diameter of about 500 40 face of a strain gauge in a linear pattern, this is not a require- 
nanometers (nm) or less, about 100 nm or less, about 50 nm or 	 ment of the devices, and the luminescent materials can be 
less, or about 20 mu or less. Luminescent nanoparticles can 	 applied in any suitable fashion. By way of example, FIG. 3 
exhibit high quantum efficiency, stability, and a relatively 	 illustrates an example of micropatterned luminescent mate- 
long lifetime to allow efficient energy transfer. In one 	 rials formed with a bioforce enabler on a glass substrate. This 
embodiment, the particle can have a diameter of from about 5 45 technique allows sub-micrometer precision in depositing 
mu to about 10 µm. 	 droplets containing a luminescent material (e.g., upconver- 
Particles can generally be of any shape. For instance, par- 	 sion particles) over large areas using anAFM-like technique. 
ticles can be generally circular, ovoid, amorphous, or spindle 	 In principle, the sensitivity of a moire-type strain gauge is 
shaped. The shape of a particle can generally depend upon 	 limited by the width of the pattern elements of the lumines- 
materials of formation and/or formation conditions. 	 50 cent materials. For a given line width, sensitivity is ultimately 
The luminescent material can generally exhibit an emis- 	 limited by shot noise in the intensity of the color channels in 
sion lifetime on the order of microseconds (µs), e.g., about 15 	 the detector which limits acquisition speed. Preliminary 
µs or less, such as from about 1 to about 10 µs. 	 results demonstrate a noise level of —0.1% dynamic range. 
Referring again to FIG. 1, a moire-type strain gauge can 	 This may be improved by more accurately spaced lines and 
include a luminescent material in one or more areas 14 on a 55 color pallet. In one embodiment, systematic errors due to 
surface of the lower plate 4. In one embodiment, the strain 	 changes in lighting, camera distance, camera angle, and hys- 
gauge can include first areas 14 that include a first lumines- 	 teresis can be held to a level less than or comparable to 1% of 
cent material 14 and second areas 12 that include a second 	 the dynamic range. While not wishing to be bound to any 
luminescent material. The emission of the two areas 12, 14 	 particular theory, it is believed that distance and angle effects 
will differ from one another. 	 60 can be minimal, provided that the area of luminescent mate- 
The plates 2, 4 can be arranged so that only one area 14 or 	 rial can be clearly resolved. Light conditions (e.g. indoors vs. 
12 can be viewed through the window at a time. For instance, 	 outdoors in external structural applications, or spectral dis- 
the area 14 that includes the luminescent material can have a 	 tortion from tissue scattering in internal applications) may 
linewidth substantially equal to the width of the window 10 	 cause significant interference and nearby calibration stan- 
such that at most one emission spectrum is visible through the 65 dards may be needed to adjust for light conditions. For 
window that is located above the area. For example, when the 	 example, reference standards may be used to account for 
device of FIG.1 is under little or no strain, each area 12 can be 	 tissue scattering based upon one or several points. A one point 
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calibration corresponds to a region with a known spectrum 
that is illuminated through the tissue to measure the effect of 
tissue absorption and scattering on the luminescence spec-
trum. This single reference could be located at a specific 
region of the implant or could be excited by an alternate 
mechanism than the patterned substrate in the strain gauge 
(e.g. X-ray luminescence when the patterned strain gauge 
excites with 980 mu light, or an Er-doped upconversion ref-
erence that excites with 1523 mu light, or an upconversion 
phosphor that excites by sequential absorption of photons 
from two different near infrared wavelengths). A preferred 
embodiment for a two point calibration would be two regions, 
one with a luminescence spectrum corresponding to the strain 
gauge at one end of its dynamic range, and a second region 
with a luminescence spectrum corresponding to a pattern at 
the other end of its dynamic range. These reference regions 
could be formed by fixing (e.g. gluing) a mask to a patterned 
substrate positioned so that only one luminescent feature 
could be seen through either gauge. A third standard region 
wouldbe a "dark region" coated with a thin layer of an opaque 
material such as a black carbon pigment or a reflective mate-
rial such as aluminum. 
There can be a trade-off between sensitivity and dynamic 
range of the strain gauge. Smaller lines provide greater dis-
placement sensitivity but have a smaller dynamic range. This 
conundrum can be resolved using two or more distinct lumi-
nescent materials for different areas of the gauge or spectral 
peaks that measure strain on different scales, similar to a 
vernier scale (e.g. red/blue measures displacements from 
2-100 µm, green/black measures displacement from 50-500 
µm). 
Referring again to FIG. 1, the upper plate 2 and lower plate 
4 can be connected to each other, for instance by use of pliable 
walls, posts, or the like such that the upper and lower plates 
can move with respect to one another. For instance, as shown 
in FIG. 1, sidewalls 6 (shown in dashed lines) may be utilized 
to couple the upper plate 2 to the lower plate 4. In one 
embodiment, the upper and lower plates can be connected to 
one another with a solid wall, such that the interior portion of 
the strain gauge 1 that contains the luminescent material is 
enclosed. This may be desired in one embodiment to isolate 
the luminescent materials from the surrounding environment, 
but it is not a required feature of the device. In another 
embodiment, the upper plate 2 and lower plate 4 can be 
independently attached to a medical device, for instance 
within a bore formed in the device, with the upper and lower 
plates 2, 4 in proper alignment with one another and the upper 
plate 2 visible at or near a surface of the implantable device. 
In this embodiment, the upper and lower plates are not 
directly attached to one another, but rather are each separately 
attached to an implantable device. 
FIG. 4 illustrates another embodiment of the strain gauge. 
According to this embodiment, the upper plate 2 and the 
lower plate 4 can be at a distance from one another and 
connected to one another with a wall 6, posts, or the like such 
that the strain gauge defines a space 8 between the upper plate 
2 and the lower plate 4. Within the space 8, the gauge can 
include an elastomer 15. 
In one embodiment, the elastomer can be a thermoplastic 
elastomer such as a siloxane polymer. Some examples of 
suitable siloxane elastomers include, without limitation, 
polydimethyl siloxanes such as dimethylvinylsiloxy end 
group-capped polydimethyl siloxane, methyldivinylsiloxy 
end group-capped polydimethyl siloxane, dimethylvinylsi-
loxy end group-capped dimethyl siloxane, (80 mol %)/meth-
ylphenylsiloxane (20 mol %) copolymers, dimethylvinylsi-
loxy end group-capped dimethylsiloxane (80 mol 
%)/diphenylsiloxane (20 mol %) copolymers, dimethylvinyl-
siloxy end group-capped dimethylsiloxane (90 mol 
%)/diphenylsiloxane (10 mol %) copolymers, and trimethyl-
siloxy end group-capped dimethylsiloxane/methylvinylsi- 
5 loxane copolymers. Besides the above-mentioned polymers, 
other polymers may also be utilized. For instance, some suit-
able vinyl-modified silicones include, but are not limited to, 
vinyldimethyl terminated polydimethylsiloxanes; vinylm-
ethyl, dimethylpolysiloxane copolymers; vinyldimethyl ter- 
lo minated vinylmethyl, dimethylpolysiloxane copolymers; 
divinylmethyl terminated polydimethylsiloxanes; polydim-
ethylsiloxane, mono vinyl, mono n-butyldimethyl termi-
nated; and vinylphenylmethyl terminated polydimethylsilox- 
15 anes. Further, some methyl-modified silicones that can be 
used include, but are not limited to, dimethylhydro terminated 
polydimethylsiloxanes; methylhydro, dimethylpolysiloxane 
copolymers; methylhydro terminated methyloctyl siloxane 
copolymers; and methylhydro, phenylmethyl siloxane 
20 copolymers. 
In conjunction with the elastomer 15, the gauge can include 
a luminescent material that can exhibit a difference in emis-
sion depending upon the pressure of the material's surround-
ing environment. For instance, the gauge can include lumi- 
25 nescent particles 12 that can be, e.g., upconversion particles 
and/or surface enhanced Raman spectroscopy nanoparticles 
embedded in the elastomer 15. In one embodiment, the par-
ticles can be functionalized, for instance by use of silane 
chemistry, and encapsulated in a thin silica film prior to being 
30 incorporated in the elastomeric polymer. This can prevent any 
unwanted interactions with bodily fluids and effectively 
eliminate any potential cytotoxicity of the luminescent mate-
rial. During use, changes in strain to the gauge can displace 
the upper plate 2 relative to the lower plate 4 and cause an 
35 increase in pressure in the elastomer 15. This increased pres-
sure can, in turn, lead to spectral changes in the detectable 
emission of the luminescent particles 12 embedded in the 
elastomer 15. 
In one embodiment, the gauge can further include a lumi- 
40 nescent dye between the luminescent particles 12 and the 
upper plate 2. In this embodiment, pressure applied to the 
device can increase or decrease the amount of dye visible 
through the window of the upper plate 2, which can further 
alter the characteristics of the emission that is visible through 
45 the window of the upper plate 2. 
According to this embodiment, upconversion lumines-
cence from the particles 12 can pass through the elastomer 15 
between the particles 12 and the window in the upper plate 2 
as illustrated by the directional arrows in FIG. 4. The thick- 
5o ness of the elastomer 15 between the particles 12 and window 
can increase or decrease under tension. The elastomer can be 
dyed with luminescent dye, for instance a near infrared 
absorbing dye, providing a tension/path length-dependent 
emission spectrum. According to Beer's law, the transmit- 
55 tance through an absorptive film is given by: T—IO- b,  For 
example, when considering the fluorophore Cy7 E (780 nm) —of 
1.5x105 M- 'cm i , and E(800 nm) =4x104 . Thus, a 1 mM layer 
100 µm thick will transmit only 3% of 780 nm light, but 40% 
of 800 mu light, while a 1 µm path length will transmit at 97% 
6o and 99% respectively. The log of the peak ratio is expected to 
be proportional to tension. The slope of the log depends upon 
the wavelengths selected, which provides a large dynamic 
range. A calibration curve can be obtained by measuring the 
luminescence spectrum under different loads applied by a 
65 universal testing machine. Calibrations can be performed at 
different tissue depths and polynomial fitting can be carried 
out to account for nonlinearities due to the specific fluores- 
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cence of the dye, absorption of scattered light by the elas-
tomer, and the finite width of the band pass. 
FIG. 5 illustrates the emission intensity of a strain gauge as 
illustrated in FIG. 4 under tension (pressure) and under no 
tension (contact). As can be seen, the emission intensity var-
ies greatly depending upon the strain condition of the gauge, 
and thus the strain of the system can be determined relatively 
simply through examination of the emission spectrum of the 
gauge. 
During use, tissue scattering, absorption and thickness can 
affect the upconversion and radioluminescence spectrum of 
the luminescent materials and thus strain accuracy. Based 
upon photon migration models and preliminary results, it is 
believed that the intensity of radioluminescence can decrease 
by an order of magnitude with increasing tissue depth and 
there will be a red-shift in luminescence of collected light that 
can be overcome by either using closely space spectral refer-
ence peaks or lifetime-based detection. In any case, there can 
be sufficient signal for measurements up to several centime-
ters deep. 
Beneficially, a strain gauge can be easily sized to be accom-
modated into or onto any desired implantable device. For 
instance, the base of a gauge can be of any suitable shape 
including square, rectangular, triangular, etc. with a maxi-
mum cross sectional dimension of about 1 cm 2 or less. A 
gauge can generally have a relatively small height, with a 
distance between the upper plate 2 and the lower plate 4 of 
about 1 mm or less, for instance about 400 µm or less. Thus, 
a strain gauge can be located within or on an implantable 
device with the upper plate 2 either flush or below the surface 
of the device, though the upper plate of the device should be 
available for detection of the luminescent emission from the 
window(s) of the device. 
In addition, the strain gauges can be sterilizable, e.g., auto-
clavable, so as to be incorporated in an implantable device 
and sterilized prior to implantation. They can also be sealed in 
a sterile container prior to use. 
The strain gauges can be utilized in conjunction with any 
implantable structural devices such as, without limitation, 
fixation devices such as bolts, screws, pins, balloon catheters, 
stents, etc. In another embodiment, the implantable device 
can be a less rigid device. For example, the strain gauge can be 
associated with an implantable gel that can interact with the 
surrounding tissues and provide information with regard to 
localized pressure. For instance, a strain gauge can be incor-
porated with an implantable gel that can swell or contract in 
response to an analyte. Upon interaction with the analyte, the 
tension of the gel can change due to the swelling/contraction, 
and the strain gauge can exhibit a variation in the luminescent 
spectrum that can then be detected as described herein. Ana-
lytes that can be detected by use of such an embodiment can 
include both physical and chemical analytes including, with-
out limitation, glucose, proteins (e.g., enzymes such as pro-
teases), temperature, pH, electrostatic interactions, etc. 
FIG. 6 is a schematic for a tension indicating bolt that can 
incorporate a moire-type strain gauge 20 as described herein. 
An opening 22 in the bolt head can allow one to observe the 
emission from the strain gauge 20 that is pressed against the 
opening 22 by a central pin 24 below and a spring 26 on the 
left. When the bolt is under tension, the central pin 24 can 
extend away from the window 22 as shown by the lower 
directional arrow in FIG. 6, allowing the spring 26 to urge the 
strain gauge to the right. Displacement of the gauge is 
observed as an emission change as a different pattern line 
becomes visible through the window 10 due to the reference 
pattern of luminescent material in the strain gauge 20. In one 
embodiment, the bolt and/or the strain gauge can include 
structures so as to maintain proper alignment of the gauge 
within the bolt. For instance, the gauge and orbolt can include 
a dovetail, a trench and matching extension, or the like such 
that the gauge 20 and the surrounding bolt are aligned and 
5 proper alignment is maintained during operation. 
FIG. 7 schematically illustrates a tension indicating bolt 
that can incorporate a strain gauge as illustrated in FIG. 4. 
According to this embodiment, when the bolt is under ten-
sion, it elongates and causes the central pin 24 to extend away 
10 from the opening 22 and alter the tension on the gauge. 
Displacement of the gauge is observed as an emission change 
as the pressure on the elastomer 15 in the gauge varies, which 
causes a variation in the emission spectra from the lumines-
cent particles 12, the variation being visible throughthe open- 
15 ing 22. 
When considering an implantable device such as a bolt, at 
proper bolt tension, the bolt strain is proportional to stress: 
e —a/E, where c is the bolt strain (AL/L o), a is the stress, and 
E is the young's modulus. For carbon steel, the young's 
20 modulus E —200 GPa, and 90% of the yield stress is —500 
MPa. Therefore, the strain at 90% of yield stress corresponds 
to 25 µm elongation per centimeter of bolt length, or 64 µm 
elongation for a 1 inch long bolt. In FIG. 6, the pressure of the 
central pin 24 against the gauge forces the gauge left causing 
25 a change in emission visible through the window 10. Elon-
gation of the bolt by 64 µm releases the strain gauge to the 
right by 64 */m, where m is the slope of the member's inclined 
plane. For a slope of 2, a 90% strain corresponds to a lateral 
displacement of about 130 µm. Thus, in one embodiment, the 
30 strain gauge can exhibit a variation in detected luminescence 
in this 130 µm range. 
It should be appreciated that the disclosed strain gauges 
may be used to measure residual strain when an implant is 
unloaded, or may measure the stiffness when strains are 
35 applied. To measure the stiffness of a loaded/strained implant, 
any suitable force application means may be used to apply a 
force against the implant in vivo. For example, in one embodi-
ment, loads may be applied indirectly to the implant, such as 
by having a patient bare weight on a scale. Alternatively, loads 
40 may be applied directly to the implant, such as by using 
magnets or any other suitable load application device. For 
example, magnetic field gradients may be used to apply a 
force to magnetic components on the implant, or oriented 
magnetic fields may be used to apply torques. It has been 
45 found that the use of magnetic forces to apply loads to 
implants has several advantages, namely that the magnetic 
forces may be applied non-invasively through tissue, may be 
easily modulated to modulate the strain and improve signal to 
noise ratio, and may be used in extendable/contractable 
50 orthopedic devices. Alternatively, loads may be applied to the 
implant using any other suitable means, such as by using 
thermally triggered materials (e.g., shape memory materials). 
The present invention may be better understood with ref-
erence to the Examples described below. 
55 
Example 1 
A strain gauge as illustrated in FIG. 2 was formed. The 
gauge included a series of lines that were printed with a color 
60 laser printer on a piece of paper and detected with a Nikon 
D90 digital camera. The lower plate was the paper that 
included the series of lines. A transparent film was utilized as 
a window layer. The lines were 500 M thick, providing a 
dynamic range of 500 µm; a root mean square displacement 
65 resolution of 10 µm was obtained (root mean square displace- 
ments of less, for instance about 0.5 µm can be obtained in 
other embodiments). The transparency was made to slide 
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smoothly above the patterned paper by folding the sides of 
paper around the edges of the transparency to make a rail (in 
place of the folded paper rail, more recent version have used 
laminating pouches). FIG. 8 shows results of the strain gauge 
used to measure displacement in a bone fracture mimic. The 
strain can be applied to a wide variety of other structural 
components. 
The ratio between normalized red and total (blue+red) 
intensities varied linearly with strain. The line was a least 
squares linear fit to the points; a noise level of +/-10 µm rms 
was observed, corresponding to 670 µstrains for the 1.5 cm 
long strain gauge. The insets are photos of the strain gauge at 
the three circled points. 
Another strain gauge with 500 µm lines was then attached 
to a 316 stainless steel dog bone-shaped specimen. The speci-
men was stretched in an Instron mechanical testing machine 
under a force ramp. Displacement was measured with the 
instron's linear variable differential transformer (LUDT) sen-
sor and by measuring the color of the optical strain gauge with 
a Nikon D90 digital camera. The short term noise on the 
digital camera was -0.5 µm, corresponding to 0.1 % of the line 
width, and the shape of the displacement curve with the 
optical gauge agreed well with the LUDT. 
Example 2 
A mimic of a femur bone fracture was formed and an 
optical moire phase-type strain gauge was attached to the 
fracture fixator as illustrated in FIG. 9A. The visible color of 
the gauge varied when it underwent strain. The visible pattern 
of the optical strain gauge measuring the strain between the 
two surfaces changed color from red (FIG. 9A and FIG. 913) 
under no strain to blue (FIG. 9C) upon application of stress. 
Example 3 
A strain gauge including a film of upconversion lumines-
cent material Gd 2o2S:Yb/Eu microparticles (Phosphor Tech-
nologies Inc. product number PTIR475/F) embedded in a 
layer of polydimethylsiloxane was formed and including a 
crystal violet dye held in the gauge in conjunction with the 
luminescent material and the polydimethyl siloxane. 
FIG. 10A illustrates the experimental setup including the 
sample and a 980 mu diode laser used to excite the lumines-
cent material of the sample. The emission was collected via 
fiber-coupled collection optics and sent through a short pass 
filter to block out the excitation signal prior to the emission 
spectrum being detected by use of a spectrometer. 
FIG. 10B is an image of the strain gauge without pressure 
applied, and FIG. 10C illustrates the spectrum from the gauge 
without pressure. As can be seen the emission spectrum 
shows only spectral peaks at greater than 750 mu. FIG. 10D 
illustrates the strain gauge after application of pressure, 
which displaced the dye held in the gauge. The spectrum of 
the gauge during the application of pressure (FIG. 10E) 
shows multiple spectral peaks below 750 nm. FIG. 1OF illus-
trates the intensity of the 800 mu peak in time, acquired every 
2 seconds, as pressure was rapidly applied at 150 seconds and 
again at 190 seconds. 
Example 4 
To show that the approach can apply to low modulus mate-
rials such as tendons as well as high modulus materials such 
as bones and steel, force was applied to a rubber section using 
a spring strain gauge, and the induced strain was measured by 
two methods: (a) looking at the color of a reflective strain 
14 
gauge fixed to the rubber at two spots using clamps, and (b) 
using a ruler to measure the position of the two clamps. Stress 
and strain were calculated from load and displacement taking 
into account the length and cross-section of the rubber speci- 
5 men. The two methods gave similar stress/strain curves. 
Example 5 
To show that magnets can be used to apply an external force 
10 to the disclosed strain gauges, iron staples were added to a 
piece of rubber associated with an optical strain gauge so that 
moving a magnet near the stapled end applied a force to the 
rubber. The resulting displacement was detected on the opti- 
15 cal strain gauge. 
Those skilled in the art will appreciate that such application 
of a magnetic force may achieved in variety of different ways 
including using magnetic materials with high coercivity (e.g., 
permanent magnets including but not limited to Alnico, 
20 NdFeB, or SmCo) or soft magnetic materials (e.g., including 
Fe, Ni, Co and allows thereof). Moreover, in addition to 
forces, torques may also be applied. For example, a 800 kA/m 
external magnetic field oriented 90 degrees to a 0.1 cm 3 
NdFeB magnet with magnetization of I T would generate an 
25 in situ torques of -0.08 Nm. Thus, if the magnet is attached to 
an extension screw with 40 threads per inch (10 -4 m/radian), 
such toque generates 80 N of axial force, assuming negligible 
friction. Of course, greater forces are possible using larger 
magnets and/or hydraulic systems or differential screws to 
30 increase the mechanical advantage. 
It should also be appreciated that one may estimate the 
force from the magnetic properties of the material as well as 
the external magnetic field, but several assumptions may be 
needed for the calculations (for example, the field gradient 
35 depends upon the distance of the external field from the 
magnetic sample). An alternative may be to attach the exter-
nal permanent magnet or electromagnet to a force and/or 
torque gauge and measure the force/torque on the external 
magnet as it approaches the implant. 
40 	 While the subject matter has been described in detail with 
respect to the specific embodiments thereof, it will be appre-
ciated that those skilled in the art, upon attaining an under-
standing of the foregoing, may readily conceive of alterations 
to, variations of, and equivalents to these embodiments. 
45 Accordingly, the scope of the present disclosure should be 
assessed as that of any appended claims and any equivalents 
thereto. 
What is claimed is: 
50 	 1. An implantable strain gauge comprising: 
a first plate; 
a second plate that is located at a distance from the first 
plate, the second plate including a window, the second 
plate being movable relative to the first plate from a first 
55 position to a second position upon application of a ten-
sion to the strain gauge, the first and second plates being 
configured to be implanted within tissue; 
a luminescent material, the luminescent material emitting a 
detectable emission upon excitation by irradiation, the 
60 emission of the luminescent material being detectable 
through the tissue, wherein at the first position the emis-
sion of the luminescent material is detectable through 
the window and at the second position either no lumi-
nescent emission is detectable through the window or a 
65 second luminescent emission is detectable through the 
window that differs from the emission detected through 
the window at the first position. 
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2. The implantable strain gauge of claim 1, wherein the 
luminescent material is located on an upper surface of the first 
plate. 
3. The implantable strain gauge of claim 2, wherein the 
luminescent material is located on the upper surface of the 
first plate in a pattern comprising multiple pattern elements. 
4. The implantable strain gauge of claim 1, further com-
prising a second luminescent material, an emission of the 
second luminescent material being detectable through the 
tissue, wherein at the second position, the emission of the 
second luminescent material is detectable through the trans-
parent window. 
5. The implantable strain gauge of claim 1, wherein the 
second plate includes multiple windows. 
6. The implantable strain gauge of claim 1, wherein the 
emission of the luminescent material is in the visible to near 
infrared wavelengths. 
7. The implantable strain gauge of claim 1, wherein the 
luminescent material is excited by near-infrared, infrared, or 
x-ray irradiation. 
8. The implantable strain gauge of claim 7, wherein the 
luminescent material is excited by near-infrared or infrared 
irradiation and the emission is at near-infrared or infrared 
wavelengths. 
9. The implantable strain gauge of claim 1, wherein the 
luminescent material is an upconversion material or a surface 
enhanced Raman spectroscopy material. 
10. The implantable strain gauge of claim 1, the strain 
gauge including a particle that comprises the luminescent 
material. 
11. The implantable strain gauge of claim 1, further com-
prising an elastomer located between the first plate and the 
second plate. 
12. The implantable strain gauge of claim 11, wherein the 
luminescent material exhibits a different emission depending 
upon the pressure of the luminescent material's surrounding 
environment. 
13. The implantable strain gauge of claim 11, further com-
prising a second luminescent material, at least one of the first 
and second luminescent materials being a luminescent dye. 
14. The implantable strain gauge of claim 1, wherein the 
first plate is coupled to the second plate. 
16 
15. The implantable strain gauge of claim 14, further com-
prising a wall coupled between the first and second plates. 
16. The implantable strain gauge of claim 1, wherein the 
window is transparent or semi-transparent. 
5 	 17. The implantable strain gauge of claim 1, wherein the 
first and second plates are sterilizable. 
18. An implantable device comprising the implantable 
strain gauge of claim 1. 
19. The implantable device of claim 18, wherein the 
10 implantable device is a fixation device. 
20. The implantable device of claim 18, wherein the 
implantable device comprises an implantable gel. 
21. A method for detecting loads on an implant, the method 
15 comprising: 
detecting a first emission from a luminescent material 
through living tissue, the first emission being in response 
to excitation of the luminescent material by irradiation 
of the luminescent material, the luminescent material 
20 	 being a component of a strain gauge, the strain gauge 
being a component of the implant; 
detecting a second emission from the strain gauge through 
the living tissue; and 
determining a variation in strain placed upon the implant 
25 	 according to the variation between the first emission and 
the second emission. 
22. The method of claim 21, wherein the first emission and 
the second emission vary by wavelength. 
23. The method of claim 21, wherein the first emission and 
30 the second emission vary by intensity. 
24. The method of claim 21, wherein the first and second 
emissions are detectedthrough about 10 centimeters or less of 
tissue. 
35 	 25. The method of claim 21, wherein the first and second 
emissions are detected with a camera or a spectrometer. 
26. The method of claim 21, further comprising exciting 
the luminescent material. 
27. The method of claim 26, wherein the luminescent mate-
40 rial is excited by use of near infrared, infrared, or x-ray 
irradiation. 
